Work

BFAST but be smart: bTMB remains an exploratory biomarker in NSCLC

Year: 2022

Type: other

Source: Nature Reviews Clinical Oncology

DOI: 10.1038/s41571-022-00698-y

Authors: So Yeon Kim, Roy S. Herbst

Institutions: Yale Cancer Center, Yale University

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4307028279

Cites: 10

Cited by: 5

Related to: 10